United States · FDA National Drug Code directory
Fexofenadine HCl and Pseudoephedrine HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-823_d024126e-de41-3d5e-73d8-bbb2623037e6
- Product NDC
- 43598-823
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Fexofenadine HCl and Pseudoephedrine HCI
- Labeler
- Dr. Reddy's Laboratories Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190718
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 60 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (43598-823-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-823-14
- 6 BLISTER PACK in 1 CARTON (43598-823-31) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-823-31
- 2 BLISTER PACK in 1 CARTON (43598-823-35) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 43598-823-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →